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STUDY QUESTION: Can bovine oocyte antioxidant defence and oocyte quality be improved 24 
by extending the duration of pre-in vitro maturation (IVM) with cyclic adenosine 25 
mono-phosphate (cAMP) modulators? 26 
SUMMARY ANSWER: Lengthening the duration of cAMP-modulated pre-IVM elevates 27 
intra-oocyte reduced glutathione (GSH) content and reduces hydrogen peroxide (H2O2) via 28 
increased cumulus cell-oocyte gap-junctional communication (GJC), associated with an 29 
improvement in subsequent embryo development and quality. 30 
WHAT IS KNOWN ALREADY: Oocytes are susceptible to oxidative stress and the oocyte’s 31 
most important antioxidant glutathione is supplied, at least in part, by cumulus cells. A 32 
temporary inhibition of spontaneous meiotic resumption in oocytes can be achieved by 33 
preventing a fall in cAMP, and cyclic AMP-modulated pre-IVM maintains cumulus-oocyte GJC 34 
and improves subsequent embryo development.   35 
STUDY DESIGN, SIZE, DURATION: This study consisted of a series of ten experiments 36 
using bovine oocytes in vitro, each with multiple replicates. A range of pre-IVM durations were 37 
examined as the key study treatments which were compared to a control. The study was 38 
designed to examine if one of the oocyte’s major antioxidant defences can be enhanced by 39 
pre-IVM with cAMP modulators, and to examine the contribution of cumulus-oocyte GJC on 40 
these processes.  41 
PARTICIPANTS/MATERIALS, SETTING, METHODS: Immature bovine cumulus-oocyte 42 
complexes were treated in vitro without (control) or with the cAMP modulators; 100 μM 43 
forskolin (FSK) and 500 µM 3-isobutyl-1-methyxanthine (IBMX), for 0, 2, 4 or 6 h (pre-IVM 44 
phase) prior to IVM. Oocyte developmental competence was assessed by embryo 45 
development and quality post-IVM/IVF. Cumulus-oocyte GJC, intra-oocyte GSH and H2O2 46 
were quantified at various time points during pre-IVM and IVM, in the presence and absence 47 
of functional inhibitors: carbenoxolone to block GJC and buthionine sulfoximide (BSO) to 48 
inhibit glutathione synthesis.  49 
MAIN RESULTS AND THE ROLE OF CHANCE: Pre-IVM with FSK+IBMX increased 50 





regardless of pre-IVM duration. The final blastocyst yields (proportion of blastocysts/immature 52 
oocyte) were 26.3% for the control, compared to 39.2%, 35.2% and 34.2%, for the 2 h, 4 h 53 
and 6 h pre-IVM FSK+IBMX treatments, respectively. In contrast to standard IVM (control), 54 
pre-IVM with cAMP-modulators maintained open gap-junctions between cumulus cells and 55 
oocytes for the duration (6 h) of pre-IVM examined, and persisted for a further 8 h in the IVM 56 
phase. Cyclic AMP-modulated pre-IVM increased intra-oocyte GSH levels at the completion 57 
of both pre-IVM and IVM, in a pre-IVM duration-dependent manner (P < 0.05), which was 58 
ablated when GJC was blocked using carbenoxolone (P < 0.05). By 4 h of pre-IVM treatment 59 
with cAMP-modulators, oocyte H2O2 levels were reduced compared the control (P < 0.05), 60 
although this beneficial effect was lost when oocytes were co-treated with BSO. Inhibiting 61 
glutathione synthesis with BSO during pre-IVM ablated any positive benefits of 62 
cAMP-mediated pre-IVM on oocyte developmental competence (P < 0.01).  63 
LIMITATIONS, REASONS FOR CAUTION: It is unclear if the improvement in oocyte 64 
antioxidant defence and developmental competence reported here is due to direct transfer of 65 
total and/or reduced glutathione from cumulus cells to the oocyte via gap-junctions, or 66 
whether a GSH synthesis signal and/or amino acid substrates are supplied to the oocyte via 67 
gap-junctions. Embryo transfer experiments are required to determine if the cAMP-mediated 68 
improvement in blastocyst rates leads to improved live birth rates. 69 
WIDER IMPLICATIONS OF THE FINDINGS: IVM offers significant benefits to infertile and 70 
cancer patients and has the potential to significantly alter ART practice, if IVM efficiency in 71 
embryo production could be improved closer to that of conventional IVF (using ovarian 72 
hyperstimulation). Pre-IVM with cAMP-modulators is a simple and reliable means to improve 73 
IVM outcomes.  74 
STUDY FUNDING/COMPETING INTEREST(S): This work was supported by grants and 75 
fellowships from the National Health and Medical Research Council of Australia (1007551, 76 
627007, 1008137, 1023210) and by scholarships from the Chinese Scholarship Council (CSC) 77 
awarded to HJL and the Japanese Society for the Promotion of Science Postdoctoral 78 
Fellowship for Research Abroad awarded to S.S. The Fluoview FV10i confocal microscope 79 
was purchased as part of the Sensing Technologies for Advanced Reproductive Research 80 





acknowledge partial support from the Australian Research Council Centre of Excellence for 82 
Nanoscale BioPhotonics (CE140100003). We declare that there is no conflict of interest that 83 
could be perceived as prejudicing the impartiality of the research reported. 84 
Key words: oocyte in vitro maturation / cyclic AMP / gap junctional communication / 85 










Conventional IVF, or the generation of embryos and pregnancies following ovarian 92 
hyperstimulation, has proven a great medical advance. Yet the technology remains inefficient, 93 
with only an 18% success rate (live birth/initiated IVF cycle; (Macaldowie et al., 2014)), it is 94 
expensive and ovarian hyperstimulation is not without significant health risks (Market-Velker 95 
et al., 2010; Seggers et al., 2014). Oocyte in vitro maturation (IVM) is a related useful 96 
technique to generate mature oocytes and embryos for clinical infertility treatment but uses 97 
minimal or no ovarian hyperstimulation (Edwards 1965).  Clinical application of IVM has 98 
remained limited due to lower embryo yield and subsequent pregnancy rates compared to 99 
conventional IVF (Nagai 2001; Gremeau et al., 2012), although recent improvements in 100 
pregnancy rates are providing significant promise (Ortega-Hrepich et al., 2013; Walls et al., 101 
2015). IVM is particularly attractive to patients who suffer from polycystic ovary syndrome as 102 
these patients have a high antral follicle count and are at risk of developing ovarian 103 
hyperstimulation syndrome during conventional IVF. Furthermore, with ever increasing cancer 104 
survival rates, IVM has an important place in modern fertility preservation approaches, using 105 
oocytes collected either from in vivo or ex vivo ovaries (Smitz et al., 2011). In recent years, 106 
improvement has been made in the efficacy of IVM in animals and translating these advances 107 
to human IVM stands to bring significant benefits to health care providers and to patients 108 
(Gilchrist et al., 2011).  109 
 110 
It is widely accepted that the low efficiencies of IVM are in part due to precocious oocyte 111 
meiotic resumption following artificial removal of cumulus-oocyte complexes (COCs) from 112 
antral follicles and subsequent culture (Gilchrist and Thompson 2007). We and others have 113 
demonstrated that a temporary inhibition of spontaneous meiotic resumption, achieved by 114 
preventing a fall in intra-oocyte cyclic adenosine monophosphate (cAMP) level through the 115 
use of cAMP modulators prior to maturation (pre-IVM), better recapitulates some of the oocyte 116 
maturation processes that occur in vivo, leading to greater oocyte developmental competence 117 
(Luciano et al., 1999; Guixue et al., 2001; Shu et al., 2008; Albuz et al., 2010; Rose et al., 118 





are several options to prevent the reduction in cAMP during this pre-IVM period, including the 120 
use of specific and non-specific phosphodiesterase (PDE) inhibitors or dibutyryl-cAMP 121 
(Funahashi et al., 1997; Gilchrist 2011).  We have previously shown that using the 122 
non-specific PDE inhibitor, 3-isobutyl-1-methylxanthine (IBMX), in conjunction with increasing 123 
cAMP synthesis in COCs with the adenylate cyclase activator, FSK, significantly improves 124 
oocyte developmental competence as measured by blastocyst development rates and 125 
post-transfer fetal yield (Albuz et al., 2010; Zeng et al., 2013; Richani et al., 2014; Zeng et al., 126 
2014). The application of cAMP-modulated IVM is now at the pre-clinical stage in human 127 
assisted reproductive technology (ART) (Spits et al., 2015). Moreover, in the mouse, 128 
blastocyst yield and quality was greater when the pre-IVM period was lengthened beyond 1 129 
hour (Richani et al., 2014) and 20 hours of dibutyryl-cAMP treatment is routinely used in 130 
porcine IVM (Funahashi et al., 1997), suggesting that the duration of cAMP-modulated 131 
pre-IVM has important effects on oocyte developmental competence. 132 
 133 
Treatment of COCs with cAMP modulators prolongs cumulus-oocyte gap junctional 134 
communication (GJC) during IVM (Thomas et al., 2004; Shu et al., 2008; Luciano et al., 2011; 135 
Franciosi et al., 2014). Bidirectional crosstalk between the oocyte and cumulus cells (CCs) 136 
are essential for oocyte growth, for enabling nutrients and other small molecules to transfer 137 
between them, together ensuring that the oocyte acquires the molecular machinery required 138 
to support early embryo development (Zuccotti et al., 1998; Albertini et al., 2001; Gilchrist et 139 
al., 2004). One such factor exchanged between CCs and the oocyte is reduced glutathione 140 
(GSH). CC-oocyte GJC has been reported to regulate intra-oocyte GSH synthesis and 141 
accumulation (de Matos et al., 1997; Nagai 2001; de Matos et al., 2002). GSH plays important 142 
roles as a reducing agent (and therefore an antioxidant) in oocyte maturation, fertilization and 143 
embryonic development (Curnow et al., 2008; Takeo et al., 2015).  We hypothesize that one 144 
mechanism by which pre-IVM with cAMP modulators improves oocyte competence is to 145 
facilitate CC transfer and accumulation of GSH within the oocyte during the pre-IVM period.  146 
Furthermore, we assessed if intra-oocyte GSH levels are increased by extending the duration 147 
of cAMP-mediated pre-IVM (2, 4, 6 h). We undertook these experiments using bovine oocytes 148 





oocyte developmental competence and the technological approaches needed to improve 150 
human IVM. 151 
 152 
Materials and Methods 153 
 154 
COC collection 155 
Bovine COCs were obtained from abattoir-derived ovaries of primarily cycling animals (but of 156 
different breeds and fecundity) and transported to the laboratory at 35-37°C within 5 h of 157 
collection. COCs were aspirated using an 18-gauge needle and a 10-ml syringe from 3-8 mm 158 
diameter follicles of mixed growth and atresia status (Sirois and Fortune 1988), and retained 159 
in follicular fluid until transferred into pre-IVM medium (Albuz et al., 2010).  160 
 161 
COC in vitro maturation 162 
Oocytes were matured in vitro using the simulated physiological oocyte maturation (SPOM) 163 
version 2 system (Zeng et al., 2014; Gilchrist et al., 2015). Differing duration of pre-IVM (0, 2, 164 
4, 6 h) was a central variable examined in most experiments. Accordingly, the ensuing IVM 165 
interval was either, 1) varied in some experiments to give a constant total time in vitro, or 2) 166 
kept constant such that total time in vitro was extended. 167 
pre-IVM 168 
Depending on the experimental design, immature COCs were removed from aspirated 169 
follicular fluid, washed three times and cultured in Vitromat (IVF Vet Solutions, Adelaide, 170 
Australia) containing 4 mg/ml fatty acid-free bovine serum albumin (BSA; ICPbio Ltd, 171 
Auckland, NZ), with or without 100 μM FSK (Sigma) and 500 μM IBMX (Sigma), during 172 
pre-IVM periods (0, 2, 4 or 6 h). Millimolar stock concentrations of the cAMP modulators were 173 
stored at —20°C dissolved in anhydrous dimethylsulphoxide (Sigma) solutions and were 174 
diluted fresh for each experiment. 175 
IVM 176 
Following the pre-IVM treatments, bovine COCs were washed three times before maturation 177 
in Vitromat + 4 mg/ml BSA + 50 μg/ml gentamycin (Sigma) + 100 mIU/ml recombinant human 178 





included thirty to forty COCs per treatment and were cultured in pre-equilibrated 500 μl drops 180 
overlaid with paraffin oil (Sigma) and incubated at 38.5°C with 6% CO2 in humidified air for the 181 
time intervals indicated. 182 
 183 
Assessment of oocytes 184 
Oocytes were stained using the orcein staining methods, as described and validated 185 
previously (Prentice-Biensch et al., 2012), for the assessment of oocyte nuclear maturation. 186 
Briefly, oocytes were stripped of CCs, mounted onto a glass slide and overlaid with a wax 187 
supported coverslip.  Denuded oocytes were fixed in ethanol: acetic acid (3:1, v/v) by using 188 
capillary action to run the solution between the slide and coverslip, then stored at 4°C for 24 h. 189 
Oocytes were stained with 1% orcein (w/v) in 45% acetic acid (v/v) for 20 min by the same 190 
process and then cleared with a mix of 20% glycerol and 20% acetic acid in water. 191 
Chromosomal configurations were evaluated using phase-contrast microscopy (Olympus; 192 
Tokyo, Japan) and the stages of meiosis recorded.  193 
 194 
Intra-oocyte GSH content was measured as described previously (Keelan et al., 2001) using 195 
monochlorobimane (MCB, Sigma), a probe which reacts with reduced thiol groups (-SH) to 196 
form fluorescence adducts. As MCB has the highest affinity for GSH, 99% of positive 197 
fluorescence is attributed to binding with GSH (Keelan et al., 2001). COCs were cultured 198 
intact for variable intervals depending on the treatment, oocytes were denuded of CCs and 199 
then incubated in wash medium (Vitrowash, IVF Vet Solutions) containing 12.5 μM MCB at 200 
39°C in darkness for 30 mins. Oocytes were washed twice in wash medium and transferred to 201 
5 μl of wash medium overlaid with paraffin oil in a glass bottom confocal dish (Cell E&G; 202 
Houston, TX, USA). Oocytes were examined by using an Olympus Fluoview FV10i confocal 203 
microscope (Olympus; Tokyo, Japan) with an excitation wavelength of 358 nm and emission 204 
461 nm.  Relative differences in GSH content, represented by the MCB-GSH fluorescence, 205 
were determined using ImageJ software 1.33u (National Institutes of Health, Bethesda, MD, 206 
USA) and normalized to the mean value of the background (excluding oocytes) in each image.  207 
Microscope laser settings were standardized using Inspeck green fluorescence beads 208 






Intra-oocyte H2O2 levels were measured by peroxyfluor-1 (PF-1), a specific fluorophore for 211 
H2O2 (with some cross-reactivity with ONOO-, as previously described (Purdey et al., 2015).  212 
In brief, following denuding, oocytes were transferred to wash medium containing 100 μM 213 
PF-1 at 39°C in darkness. After 30 min incubation, oocytes were washed once in VitroWash, 214 
and oocytes transferred into 5 μl of wash medium overlaid with paraffin oil in a glass bottom 215 
confocal dish. Fluorescence intensity was determined by confocal microscopy (excitation: 488 216 
nm, emission: 520 nm) using the same procedure as described above.  217 
  218 
Assessment of CC-oocyte GJC 219 
Assessment of GJC between CCs and the oocyte during pre-IVM or IVM was determined by 220 
lucifer yellow (LY; Sigma) dye transfer following microinjection of dye into the ooplasm of 221 
intact COCs, as previously described (Luciano et al., 2004). Briefly, a 3% w/v LY solution in 5 222 
mM lithium chloride was injected into the oocyte. If CC-oocyte gap junctions are open then the 223 
dye is free to diffuse into the CCs which can be observed and scored, whereas no dye 224 
transfer occurs if GJC has ceased.  The transfer of dye to surrounding CCs was assessed by 225 
confocal microscope within 15 min of injection. Using a qualitative scoring system a 226 
semi-quantitative GJC index can be calculated (Sugimura et al., 2014). In brief, CC LY levels 227 
were scored as +2 when the dye was transferred to the entire cumulus layer; +1 when the dye 228 
was transferred to limited number of CC layers (primarily the corona radiate); and 0 when 229 
there was minimal to no dye transfer into any CCs.  230 
 231 
In vitro embryo production and differential staining 232 
In vitro embryo production followed methods previously described (Hussein et al., 2006). In 233 
brief, following IVM, COCs were washed twice in wash medium and co-cultured with motile 234 
sperm from a single bull of proven fertility (prepared using a discontinuous Percoll gradient, 235 
GE Healthcare) in 500 μl of pre-equilibrated IVF medium (VitroFert, IVF Vet Solutions, + 4 236 
mg/ml BSA + 10 IU/ml heparin), at a final concentration of 1 × 106/ml frozen-thawed sperm 237 
and cultured at 38.5°C in 6% CO2 in humidified air. After 22 h from the addition of sperm (day 238 





5-10 in 20 μl drops of VitroCleave (IVF Vet Solutions) + 4 mg/ml BSA, overlaid with paraffin oil 240 
at 38.5°C in 7% O2, 6% CO2, N2 balance. On day 5, 5-10 embryos were transferred into 20 μl 241 
of VitroBlast (IVF Vet Solutions) + 4 mg/ml BSA, overlaid with paraffin and cultured at 38.5°C 242 
in 7% O2, 6% CO2, N2 balance. The rates of early and final cleavage embryo development 243 
were assessed at 22 h on day 1 and day 5, respectively. Blinded embryo assessments, 244 
including yield of blastocysts and hatched blastocysts, were performed on day 8. On day 8 245 
post IVF, blastocysts in each group were processed using a differential staining protocol to 246 
determine inner cell mass (ICM) and trophectoderm (TE) cell numbers, as previously 247 
described (Hussein et al., 2006). Differential staining was performed as ICM cell numbers 248 
provide a robust measure of blastocyst quality, implantation and fetal developmental potential 249 
(Lane and Gardner 1997; Sudiman et al., 2014). The zona pellucida was removed by 250 
incubation in 0.5% pronase in Dulbecco’s phosphate-buffered saline (PBS) at 39°C. Embryos 251 
were washed in protein-free PBS and incubated in 10% 2,4,6-trinitrobenzene sulfonic acid in 252 
PBS for 10 min at 4°C in the dark; 10 mins in anti-2,4-dinitrophenol (1:10 w/v) at 39°C, 253 
followed by 10 mins in complement (2 μg/ml solution of propidium iodide: guinea pig serum, 254 
1:1). Embryos were transferred to (97%) ethanol containing 25 μg/ml of Hoechst 33342 255 
(bisbenzimide) at 4°C for overnight staining. Embryos were mounted on microscope slides in 256 
100% glycerol and the number of ICM and TE cells was determined using an epifluoresence 257 
microscope (excitation = 340-380 nm and emission = 440-480 nm), whereby nuclei appeared 258 
blue and pink, respectively. 259 
 260 
Statistical analysis 261 
Number of COCs per treatment and data set replicate numbers are provided in the figure 262 
legends for each experiment. Proportional data for embryo development were arcsine 263 
transformed before statistical analyses.  Treatment effects were assessed by one-way or 264 
two-way ANOVA followed by Turkey’s multiple-comparison post-hoc test to identify individual 265 
differences between means, using Prism 5.00 GraphPad for Windows (GraphPad Software, 266 
San Diego, CA, USA).  Two sample t-tests were used where only two sample means were 267 








Effect of pre-IVM duration on bovine oocyte meiotic and developmental competence 272 
The relationship between the duration of cAMP-modulated pre-IVM and the subsequent 273 
temporal kinetics of bovine oocyte meiotic maturation remains unclear. Here we examined the 274 
effect of 0 h, 2 h, 4 h, and 6 h pre-IVM treatment with forskolin and IBMX, followed by 275 
FSH-stimulated IVM, on oocyte meiotic maturation (Figure 1). Decreased pre-IVM duration, 276 
with a combined total 20 h of culture (pre-IVM + IVM), led to an incremental increase in 277 
metaphase II (MII) rates (Figure 1). However, only the 6 h pre-IVM treatment (6 h pre-IVM + 278 
14 h IVM) yielded significantly fewer MII oocytes compared with no pre-IVM (0 h pre-IVM + 20 279 
h IVM; P < 0.05). In contrast, when the pre-IVM time varied (0 h, 2 h, 4 h, 6 h) followed by 20 h 280 
IVM, there was no difference in the yield of MII oocytes. These data demonstrate that 281 
extended pre-IVM (e.g. 6h) delays total time to MII and hence a total (pre-IVM + IVM) culture 282 
period of 26 h was chosen for oocyte developmental competence experiments. 283 
 284 
This led us to examine subsequent embryo development following pre-IVM periods of 0 h, 2 h, 285 
4 h, 6 h, combined with IVM for 24 h, 24 h, 22 h, 20 h, respectively (Figure 2A).  An increase 286 
in the yield of early cleaved embryos at 22h post-IVF was observed with 4 h and 6 h pre-IVM 287 
periods compared with no pre-IVM (P<0.05; Figure 2B), demonstrating that prolonging 288 
pre-IVM duration accelerates 2-cell embryo development, which is a strong predictor of 289 
pregnancy success (Sugimura et al., 2012). Although final cleavage rates (as assessed on 290 
day 5) were not significantly different between groups (Figure 2C), all pre-IVM treatments 291 
increased the proportion of day 8 blastocysts/total embryos cleaved compared to no pre-IVM 292 
(P<0.05; Figure 2D). Hence, the final blastocyst yields (proportion of blastocysts/immature 293 
oocyte) were 26.3% for the control, compared to 39.2%, 35.2% and 34.2%, for the 2 h, 4 h 294 
and 6 h pre-IVM treatments, respectively.  Only the 6 h pre-IVM period treatment yielded 295 
significantly more hatched blastocysts than no pre-IVM treatment (P<0.05; Figure 2E). 296 
Importantly, all the pre-IVM treatments improved blastocyst quality, reflected by an increase in 297 
total number of cells compared with no pre-IVM, made up largely by an increased ICM cell 298 





of ICM to total cells among all treatments, and was significantly different to that of no pre-IVM 300 
(P<0.05; Figure 2F inset). 301 
 302 
Effect of pre-IVM duration on bovine CC-oocyte GJC during pre-IVM and IVM stages 303 
GJC integrity was measured by assessing LY dye transfer from the oocyte to the surrounding 304 
cumulus vestment (Figure 3A) following 0 h, 2 h, 4 h, and 6 h of pre-IVM with or without 305 
forskolin and IBMX (Figure 3B), or after 0 h, 4 h, 8 h and 12 h of IVM in the presence of FSH 306 
(Figure 3C).  As shown in Figure 3B, during pre-IVM, GJC in the control group (no cAMP 307 
modulators) fell sharply and progressively until 6 h of culture. On the contrary, the GJC 308 
remained high for up to 6 h of culture in all pre-IVM groups in the presence of FSK and IBMX. 309 
With regards to the combination of pre-IVM and IVM, during the first 8 hours of the IVM phase, 310 
GJC remained significantly (P<0.05) higher than control (no pre-IVM) when COCs had been 311 
previously exposed to a cAMP-mediated pre-IVM treatment of at least 2 hours (Figure 3C). By 312 
12 h of culture no differences were observed among any groups, indicating that under these 313 
conditions, the limit to CC-oocyte GJC is 12 h of IVM. 314 
 315 
Effect of pre-IVM on the level of bovine intra-oocyte GSH content during IVM 316 
The representative images of intra-oocyte MCB fluorescence at 0 h and 24 h of IVM, 317 
indicative of GSH levels, are presented in Figure 4A. The duration of pre-IVM exposure to 318 
FSK+IBMX significantly affected intra-oocyte GSH content, with levels at the end of pre-IVM 319 
(0h IVM) significantly higher after 4 h or 6 h of pre-IVM, in comparison with 2 h and the control 320 
(no pre-IVM) group (Figure 4B; P<0.05).  This pattern persisted after 24 h of IVM, where 321 
intra-oocyte GSH was higher with increasing length of the pre-IVM period, with a significantly 322 
(P<0.05) higher content observed in the 6 h pre-IVM group compared with the control.  This 323 
indicates that longer pre-IVM periods influence intra-oocyte GSH accumulation, not only 324 
during the pre-IVM stages but also possibly throughout IVM. Based on this, we hypothesized 325 
that GSH accumulation in the oocyte from pre-IVM treatment was due to the enhanced GJC. 326 
 327 
Effect of inhibiting GJC on GSH accumulation 328 





treatment with FSK and IBMX, we treated COCs during pre-IVM with carbenoxolone (CBX), a 330 
known gap junction inhibitor which we previously validated in bovine COCs (Thomas et al., 331 
2004), and assessed LY dye transfer from the oocyte to the cumulus vestment and 332 
intra-oocyte MCB fluorescence. CBX was effective at blocking CC-oocyte GJC (Figure 5A; 333 
P<0.01) at 4 h of culture in the presence of FSK and IBMX. The intra-oocyte GSH content was 334 
significantly decreased (Figure 5B; P<0.05) by CBX in both control and FSK+IBMX treated 335 
COCs. These results provide further evidence that CCs contribute to the accumulation of 336 
GSH in the oocyte via a GJC-mediated mechanism and that intra-oocyte GSH levels are 337 
enhanced by FSK and IBMX during the pre-IVM period. 338 
 339 
Effect of inhibition of GSH synthesis on H2O2 production and embryonic development 340 
As intra-oocyte GSH levels are regarded as important in managing reducing reactive oxygen 341 
species (ROS) in the oocyte (Guerin et al., 2001), we assessed the effect of depleted oocyte 342 
GSH levels on H2O2 content of oocytes and their subsequent developmental capacity. We 343 
depleted oocyte GSH levels by treating COCs with 10 mM buthionine sulfoximide (BSO) a 344 
validated inhibitor of glutathione synthase (Sutovsky and Schatten 1997).  BSO treatment 345 
ablated the pre-IVM (FSK+IBMX)-induced increase in intra-oocyte GSH (Figure 6C; P<0.05). 346 
H2O2 production in the oocyte was evaluated with PF-1 staining (Figure 6A; (Purdey et al., 347 
2015)). Pre-IVM with FSK+IBMX significantly decreased intra-oocyte H2O2 levels (Figures 348 
6A(b) and 6B), but this response was eliminated with BSO treatment, suggesting that 349 
reduction of GSH levels coincides with an increase in H2O2 production in oocytes.  350 
 351 
The effect of inhibiting GSH synthesis during the 4 hours of pre-IVM on subsequent 352 
embryonic development was examined after IVF and embryo culture (Figure 6D). Although no 353 
significant difference in cleavage rates was observed, 4 h of BSO-treatment of oocytes 354 
significantly (P<0.01) reduced day 8 blastocyst and hatched blastocyst yields, indicating that 355 
the synthesis of GSH in the pre-IVM period has a marked effect on subsequent embryo 356 








Here we report that increasing the length of pre-IVM treatment with FSK and IBMX positively 361 
impacts GJC in bovine COCs, which in turn increases intra-oocyte GSH and lowers 362 
intra-oocyte H2O2, establishing a mechanism contributing to the improved oocyte 363 
developmental competence observed following pre-IVM in the presence of cAMP modulators. 364 
The use of cAMP modulators during pre-IVM and/or IVM, to provide a high intracellular cAMP 365 
levels within CCs and the oocyte, is associated with prolonged CC-oocyte GJC (Luciano et al., 366 
2004; Thomas et al., 2004; Thomas et al., 2004; Shu et al., 2008; Albuz et al., 2010; Franciosi 367 
et al., 2014), in addition to the inhibition, or at least a delay, in the timing of germinal vesicle 368 
breakdown (GVBD). The resumption and completion of meiosis is particularly delayed when 369 
cAMP modulating agents (FSK + IBMX) are present during pre-IVM stage and combined with 370 
cilostamide, a PDE3 inhibitor, during the IVM phase, as per the ‘simulated physiological 371 
oocyte maturation’ (SPOM) version 1 system (Albuz et al., 2010). Further work showed that 372 
the beneficial impact of the SPOM system may lie specifically in the pre-IVM period (Zeng et 373 
al., 2013; Richani et al., 2014; Zeng et al., 2014), which led to the concept of SPOM version 2 374 
(SPOMv2), wherein there is an absence of cAMP modulators during IVM (Gilchrist et al., 375 
2015), and is the system used in the current study. Numerous mechanisms have been 376 
identified as contributing to enhanced developmental competence following SPOMv2, such 377 
as enhanced COC oxygen consumption and oocyte oxidative metabolism (Zeng et al., 2013; 378 
Richani et al., 2014; Zeng et al., 2014) and accentuating epidermal growth factor (EGF) 379 
signaling in CCs (Zeng et al., 2013; Richani et al., 2014; Zeng et al., 2014). Here we add to 380 
these concepts by revealing that extending the pre-IVM period for up to 6 hours further 381 
enhances oocyte developmental competence, most likely by increasing the oocyte’s 382 
anti-oxidant defence and decreasing ROS levels. 383 
 384 
The pre-ovulatory gonadotrophin surge leads to a transient increase of cAMP in the somatic 385 
compartment of the follicle, including in CCs (Tsafriri et al., 1972; Yoshimura et al., 1992; 386 
Mattioli et al., 1994; Albuz et al., 2010), but a simultaneous fall in intra-oocyte cGMP and 387 
cAMP (Norris et al., 2009). This cAMP surge in the COC is typically impaired or absent using 388 





developmental competence, which is the impetus for developing cAMP-modulated IVM 390 
systems (Gilchrist 2011). Such IVM systems typically use a pre-IVM phase containing cAMP 391 
elevating agents; COCs are commonly exposed to cAMP modulators for 0.25 - 2 hours prior 392 
to IVM (Luciano et al., 1999; Guixue et al., 2001; Albuz et al., 2010), but this can be up to 20 393 
hours, for example using porcine oocytes (Funahashi et al., 1997) coinciding with GVBD in 394 
that species.  395 
 396 
While the beneficial effects of cAMP modulated pre-IVM on oocyte competence are well 397 
accepted, the optimal duration of pre-IVM is largely unknown. A recent study shows extending 398 
pre-IVM exposure to cAMP modulators beyond 1-2h appears beneficial to mouse oocyte 399 
quality (Richani et al., 2014). In this study we investigated the effect of 0, 2, 4 and 6 hours of 400 
pre-IVM with FSK + IBMX followed by standard IVM on subsequent embryo development. 401 
Consistent with previous studies using a 2 hour pre-IVM system, all pre-IVM durations 402 
examined here led to notable improvements in subsequent embryo development and quality, 403 
compared to standard IVM. The 6 h pre-IVM treatment had an optimal effect on oocyte 404 
development competence, as reflected in the fastest rate of 2-cell embryo formation, the 405 
highest yield of hatched blastocysts and notably the highest ratio of ICM to total cells among 406 
all treatments. It has previously been shown that rapid cleave of bovine embryos is a strong 407 
predictor of embryo quality and pregnancy success, as assessed by embryo karyotyping, 408 
expression of interferon tau and pregnancy rates (Sugimura et al., 2012). In addition, in an 409 
IVM context, it is common to see the effects of treatments that improve oocyte quality having 410 
little or no effect on MII and total cleavage rates, but manifesting in increased blastocyst rates 411 
and ICM cell numbers, both of which are associated with improved implantation and fetal 412 
survival rates (Albuz et al., 2010; Sudiman et al., 2014).  413 
 414 
One complication of using a cAMP modulated IVM system and altering the pre-IVM interval is 415 
the effect on oocyte meiotic kinetics (Gilchrist et al., 2015), which is compounded by the fact 416 
that FSK acts initially as an inhibitor and then an inducer of meiosis (Dekel et al., 1988; 417 





different pre-IVM durations with the consequence that, with a 6 hour pre-IVM internal, the IVM 419 
phase was shortened to 20 hours (total of 26 hours).  420 
 421 
In the current study, pre-IVM with FSK+IBMX fully sustained GJC functionality in COCs 422 
throughout the 6 hours examined, in notable contrast to the loss of GJC that occurred in 423 
untreated COCs. Furthermore, the effect of pre-IVM on GJC persisted a further 8 hours into 424 
the IVM phase. Hence, in the pre-IVM 6h group, GJC was higher than in control COCs for a 425 
total of 14 hours. Stimulation of CC cAMP synthesis by FSK or gonadotrophins enhances 426 
Cx43 (connexin 43) expression and stimulates phosphorylation of Cx43 at specific residues,  427 
possibly via a protein kinase A-dependent mechanism, collectively sustaining GJC 428 
functionality (Granot and Dekel 1994; Thomas et al., 2004; Yogo et al., 2006; Sasseville et al., 429 
2009). The use of FSH in conjunction with PDE inhibitors or natriuretic peptide precursor 430 
(NPPC), which leads to oocyte PDE inhibition, also sustains CC-oocyte GJC (Thomas et al., 431 
2004; Franciosi et al., 2014). In the current study, the sustained somatic cell support to the 432 
oocyte through at least half of oocyte maturation is likely to be a key factor in the enhanced 433 
quality of subsequent oocytes (Gilchrist and Richani 2013). One proposed benefit of CC 434 
support is the ordered cessation of oocyte transcription and appropriate remodeling of 435 
chromatin in preparation for meiosis (Luciano et al., 2011; Franciosi et al., 2014). Another 436 
benefit of extended CC-oocyte GJC is increased accumulation of beneficial CC nutrients and 437 
metabolites in the oocyte, such as glutathione (Gilchrist and Thompson 2007).  438 
 439 
Glutathione is the most abundant non-protein thiol in mammalian cells and the reduced form 440 
(GSH) plays a key role in cellular defence against oxidative injury as an important substrate 441 
for antioxidant enzymatic reactions that neutralize H2O2 and potentially toxic electrophiles 442 
(Franco and Cidlowski 2009). It is particularly important in mammalian oocytes where multiple 443 
actions have been described, including in oxidative stress defence (Guerin et al., 2001), 444 
sperm decondensation and male pronuclear formation (Sutovsky and Schatten 1997) as well 445 
as oocyte developmental competence (de Matos et al., 1995; de Matos et al., 1996; Curnow 446 
et al., 2010). The central role of glutathione in oocyte developmental competence is now so 447 





additives in oocyte IVM media (Thompson et al., 2007). Early cleavage stage embryos have a 449 
poor capacity to synthesize glutathione (Gardiner and Reed 1995), hence accumulation in 450 
oocytes during maturation is important for fertilization and subsequent developmental 451 
competence (de Matos and Furnus 2000).  452 
 453 
The current study demonstrates that pre-IVM with cAMP modulators increases intra-oocyte 454 
GSH, consistent with a recent study (Zeng et al., 2014). Moreover, the current results show 455 
that extending pre-IVM beyond 2 hours leads to increased GSH accumulation in the oocyte in 456 
the pre-IVM phase, with these higher levels of GSH then persisting throughout the IVM phase. 457 
Blocking functional CC-oocyte coupling using CBX greatly decreased intra-oocyte GSH 458 
content during pre-IVM, suggesting that CCs supply the additional GSH to the oocyte via gap 459 
junctions, as previously reported (Mori et al., 2000; Ozawa et al., 2010). This is consistent with 460 
the observation that GSH levels are lower in oocytes denuded of CCs and that CCs can 461 
increase intra-oocyte GSH levels, but only when they are physically coupled to oocytes (de 462 
Matos et al., 1997; Curnow et al., 2010). It is noteworthy that glutathione is predominantly 463 
synthesized in the COC in the GV to GVBD period. Upregulation of glutathione synthesis 464 
occurs rapidly in response to the pre-ovulatory gonadotrophin surge and an increase in 465 
intra-oocyte glutathione, from basal levels in GV oocytes to maximal levels in MII oocytes, is 466 
needed in preparation for fertilization and sperm head decondensation (Perreault et al., 1988; 467 
Zuelke et al., 2003). This acute phase of glutathione synthesis during the GV to GVBD period 468 
coincides exactly with the period in which oocytes and CCs are coupled via GJC (Thomas et 469 
al., 2004). Hence, our current findings suggest that an extended cAMP-modulated pre-IVM 470 
treatment leads to beneficial accumulation of GSH in the oocyte by prolonging CC-oocyte 471 
GJC. This is further supported by the observation that GSH accumulation in the oocyte is only 472 
prevented when GJC is blocked in the first half (GV-MI), but not when blocked in the second 473 
half (MI-MII), of oocyte maturation (Ozawa et al., 2010). Whilst it seems likely that this would 474 
be mediated by direct gap-junctional transfer of glutathione itself from CCs to the oocyte, with 475 
the current results, we cannot exclude the possibility that CCs are providing a critical signal 476 






The oocyte and zygote are particularly sensitive to damage by ROS and one of their principal 479 
anti-oxidant defences is GSH, allowing the conversion of H2O2 to water. Accordingly, 480 
increasing intra-oocyte GSH by cAMP-mediated pre-IVM suppressed oocyte H2O2, which in 481 
turn was negated by inhibition of glutathione synthesis during this period. This provides strong 482 
evidence that cAMP-mediated pre-IVM provides an important mechanism for oocyte defence 483 
against ROS. It would be expected that removing this defence mechanism would adversely 484 
affect oocyte quality, and indeed that is what we observed, in the form of reduced 485 
pre-implantation embryo development when oocyte GSH accumulation was prevented in just 486 
the 4 hour pre-IVM window.  487 
 488 
This study shows that extending the duration of cAMP-mediated pre-IVM, to approximate a 489 
large part of the GV-GVBD interval, leads to improvements in subsequent oocyte quality. This 490 
adds to the growing body of evidence that cAMP-mediated pre-IVM/IVM has great benefit to 491 
the oocyte in terms of its capacity to support preimplantation embryo development (Gilchrist 492 
2011). Such IVM approaches are intended to better simulate in vitro, as close as possible, the 493 
natural process of oocyte maturation in vivo. A fundamental mode of action of cAMP-mediated 494 
pre-IVM systems appears to be the retention of CC-oocyte gap-junctional coupling during the 495 
critical first half of oocyte meiosis in vitro. This enhanced functional CC-oocyte coupling 496 
affects oocyte chromatin remodeling and transcription (Luciano et al., 2011; Franciosi et al., 497 
2014), oocyte metabolism (Zeng et al., 2013; Zeng et al., 2014), and accumulation of 498 
intra-oocyte GSH (current study). As a result of prolonging GJC in COCs, GSH accumulates 499 
in the oocyte providing essential protection against oxidative stress. This provides further 500 
support to the notion that the appropriate functioning of CCs is required to provide critical 501 
metabolites to the oocyte that are required for healthy preimplantation embryo development. 502 
Given that the current lower success rate of clinical IVM is the primary impediment to its 503 
uptake, application of this simple cAMP-mediated pre-IVM technique stands to bring 504 
important benefit if applied to human ART. 505 
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Figure 1: Effect of pre-in vitro maturation (IVM) duration on bovine oocyte meiotic 
maturation. Immature cumulus-oocyte complexes (COCs) were cultured in standard IVM 
with FSH (no pre-IVM + 20 h IVM) or pre-IVM medium containing forskolin (FSK) and 
3-isobutyl-1-methyxanthine (IBMX) for 2, 4 or 6 h, then either 18, 16 or 14 h, respectively of 
standard IVM, or 20 h of IVM for each pre-IVM treatment. Metaphase II rates were assessed 
(n≥89 COCs per group over 4 replicate experiments). Data are mean ± SEM. Asterisk 
indicates bars are significantly different (P<0.05; 1-way ANOVA).  
 
Figure 2: Effect of pre-IVM duration followed by standard IVM on bovine embryo 
development. COCs were subjected to 0, 2, 4, 6 h pre-IVM culture in the presence of FSK 
and IBMX, followed by standard IVM in the presence of FSH for 24, 24, 22 or 20 h, 
respectively (A). Oocyte developmental capacity was assessed (n≥146 COCs pre group of 5 
replicate experiments) after IVF by early cleavage rate (B, cleaved embryos/immature 
oocytes at 22 h on day 1), final cleavage rate (C, cleaved embryos/immature oocytes 
assessed on day 5), blastocyst rate (D, total blastocysts/total cleaved embryos assessed on 
day 8), and hatched blastocyst rate (E, hatched blastocysts/total cleaved embryos assessed 
on day 8). Blastocyst quality (F, Day 8) was assessed by quantification of the number of 
trophectoderm (TE), inner cell mass (ICM) and total cells, and the ratio of ICM:total cells (n = 
25-29 per group). Data are mean ± SEM. Asterisk within each graph indicates significantly 
different (P<0.05; 1-way ANOVA) to the control (0h + 24h).   
 
Figure 3: Effect of pre-IVM duration on bovine cumulus-oocyte gap-junctional 
communication (GJC) during pre-IVM and IVM stages. The functional coupling between 
oocyte and cumulus cells was assessed after lucifer yellow dye injection. As shown in the 
representative images (A), gap junctions were classified as open (a), partial (b), or closed (c), 
and scored as 2, 1, 0, respectively, and the gap junction index calculated. A total of 690 
oocytes were used in these experiments (3 replicates per group). B: COCs were treated with 





lack of difference between time points within the FSK+IBMX treatment. Means with 
non-common letters (x, y, z) are significantly different (P<0.05; 1-way ANOVA) between time 
points within the control treatment. Asterisks indicate means that are significantly different 
(P<0.05; t-test) between pre-IVM treatments at that time point. C: COCs were treated with or 
without FSK + IBMX in pre-IVM for 2, 4 or 6 h, and then cultured in IVM with FSH and then 
GJC was assessed at 0, 4, 8 or 12 h of IVM.  Means with no common superscript letters “a-b, 
x-y, p-q” within a time point are significantly different (P<0.05; 2-way ANOVA).  
 
Figure 4: Effect of pre-IVM duration on bovine intra-oocyte reduced glutathione (GSH) 
levels during IVM. Intact immature COCs were subjected to 0, 2, 4 or 6 h pre-IVM culture 
with FSK and IBMX, followed by standard IVM for 0 h (end of pre-IVM treatment) or 24 h. After 
that, COCs were denuded of cumulus cells and the naked oocytes were incubated with 
monochlorobimane (MCB) to form MCB-GSH adducts, and observed under a laser scanning 
confocal microscope. A: images of oocytes from the four pre-IVM treatments at the end of 
pre-IVM (0 h IVM; upper panel) and at 24 h of IVM (lower panel). B: MCB-GSH relative 
fluorescent values from each pre-IVM group (n=10 COCs per group over 3 replicate 
experiments) at 0 h or 24 h of IVM. Means within a time point with no common superscripts 
“a-b, x-y” are significantly different (P<0.05; 1-way ANOVA).  
 
Figure 5: Effect of the blocked GJC on bovine intra-oocyte GSH. Immature COCs were 
incubated for 4 h with or without FSK + IBMX and with or without carbenoxolone (CBX), a 
known blocker of gap junctions. A: The blocking action of CBX was validated on FSK + IBMX 
treated COCs (n=10 per group over 3 replicate experiments) by assessment of the gap 
junctional index after 4 h of CBX treatment (**; P < 0.01; t-test). B: Intra-oocyte GSH content, 
represented by MCB-GSH adduct relative fluorescence value, was assessed after 4 h of 
culture (n=10 oocytes per group over 3 replicate experiments). Means with no common 
superscripts (a-c) are significantly different (P < 0.05; 1-way ANOVA). Data are mean ± SEM. 
 
Figure 6: Effect of inhibition of GSH synthesis on bovine oocyte hydrogen peroxide 





(control) or cultured with FSK + IBMX for 4 h, either in the absence (Pre-4h) or presence of 
buthionine sulfoximide (BSO; Pre-4h+BSO). COCs were then denuded and intra-oocyte H2O2 
production was detected using peroxyfluor-1 (PF-1) staining. Representative images (A) and 
quantitative levels (B) of H2O2 relative fluorescence in oocytes from the control, Pre-4h, and 
Pre-4h+BSO groups. C: The effect of inhibition of GSH synthesis by BSO was validated by 
measuring intra-oocyte MCB-GSH staining. Each data observation was made on 10 oocytes 
and the experiments were replicated three times. Columns (mean ± SEM) within a graph with 
no common superscript letters (a-b) are significantly different (P < 0.05; 1-way ANOVA). D: 
Oocyte developmental capacity was assessed on COCs subjected to 4 h pre-IVM (FSK + 
IBMX) either with or without BSO, followed by standard IVM in the presence of FSH for 24 h. 
After IVF, blastocyst and hatched blastocyst rates were assessed on day 8. Data are mean ± 
SEM; n=315 total COCs from 4 replicate experiments. Asterisk (**) within each group 
indicates significantly different (P<0.01; t-test) to the Pre-4h group. 
 
 
 
 
 
 
 
 






